Medicaments Reference, Re (No. 2)
| Jurisdiction | England & Wales |
| Year | 1970 |
| Date | 1970 |
| Court | Restrictive Practices Court |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
4 cases
-
F Hoffmann La Roche & Company AG v Secretary of State for Trade and Industry
...because these "ethical drugs", as they are called, are exempt from the prohibition on re-sale price maintenance, see In re Medicaments Reference (No. 2) 1970 1 W. L. R. 2So the Roche group have been given great privileges, by our English law. In addition, the market for drugs in England pl......
-
R The Pharmaceutical Society of Great Britain (Respondent (Respondent) ex parte The Association of Pharmaceutical Importers (Applicant (Appellant)
...as sui generis: see Pfizer Corporation v. Ministry of Health (1965) Appeal Cases 512 and Re Medicaments Reference (No.2) (1971) 1 All England Reports 12. (d) The reduction or virtual cessation of the applicants' trade in the 50 or so P.L. (P.I.) products Y with which this case is concerned ......
-
Freeport Concrete Company Ltd v The Crown, Comptroller of HM Customs and Attorney General
...appellant and that the question in the case should be answered in the affirmative.” 73 In the case In re Medicaments Reference (No. 2) [1970] 1 W.L.R. 1339, heard in the Restrictive Practices Court, the Resale Prices Act, 1964 was examined. The Act was concerned, inter alia, with ensuring t......
- Re Medicaments and Related Classes of Goods (No 3)
1 books & journal articles
-
Juridification, Codification and Sanction in UK Competition Law
...Seventeen sets of guidelines had been published by the time the Act came into effect on 1 March2000.23 Medicaments Reference No 2 [1971] 1 All ER 12; LR 7 RP 267 RPC.24 See Lord McNally HL Deb vol 586 col 1301 5 March 1998.25 The OFT argued that changes in market conditions meant the exempt......